logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Akadeum Life Sciences, Inc. Raises $17.5M Financing Round Led By Arboretum Ventures

Oct 12, 2021•about 4 years ago

Amount Raised

$17.5 Million

Ann Arbor

Description

Akadeum Life Sciences, Inc., today announced the closing of an oversubscribed $17.5 million Series B financing led by Arboretum Ventures. Investors in the round also included Beringea, Agilent Technologies, Lifespan Ventures, BlueStone Venture Partners, Berkeley Catalyst Fund, Michigan Capital Network, Michigan Rise, The University of Michigan, and others. The Company also announced that Dan Kidle, Managing Partner at Arboretum Ventures, has joined the Akadeum board of directors.

Company Information

Company

Akadeum Life Sciences

Location

Ann Arbor, Michigan, United States

About

Akadeum Life Sciences was formed to solve-longstanding sample preparation problems in research, diagnostics, and cell therapy markets with a novel floatation-based target isolation platform technology. Without the critical step of separation (isolating biological targets like DNA, proteins, or cells from biological samples), many diagnostics and therapies would not be possible. More than a solution to a single problem, this elegantly simple platform technology is disrupting theseparation market—from nucleic acid extraction to cell isolation. The company was the first to commercialize Buoyancy Activated Cell Sorting (BACSTM) microbubble kits for cell isolation applications. In parallel, the company is also establishing industry partnerships. The company is located in Ann Arbor, MI. To learn more about Akadeum and its products, visit https://www.akadeum.com. Inquiries into Akadeum's products or technology can be made at info@akadeum.com.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech